JP2021527071A5 - - Google Patents
Info
- Publication number
- JP2021527071A5 JP2021527071A5 JP2020568471A JP2020568471A JP2021527071A5 JP 2021527071 A5 JP2021527071 A5 JP 2021527071A5 JP 2020568471 A JP2020568471 A JP 2020568471A JP 2020568471 A JP2020568471 A JP 2020568471A JP 2021527071 A5 JP2021527071 A5 JP 2021527071A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- pharmaceutical composition
- composition according
- formula
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18305685 | 2018-06-06 | ||
| EP18305685.2 | 2018-06-06 | ||
| PCT/EP2019/064886 WO2019234197A1 (en) | 2018-06-06 | 2019-06-06 | Thieno[2,3-b]pyridine derivatives as epac inhibitors and their pharmaceutical uses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021527071A JP2021527071A (ja) | 2021-10-11 |
| JP2021527071A5 true JP2021527071A5 (https=) | 2023-11-16 |
| JP7445609B2 JP7445609B2 (ja) | 2024-03-07 |
Family
ID=62715982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020568471A Active JP7445609B2 (ja) | 2018-06-06 | 2019-06-06 | Ｅｐａｃ阻害剤としてのチエノ［２，３－ｂ］ピリジン誘導体及びその医薬用途 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20210230179A1 (https=) |
| EP (1) | EP3801511A1 (https=) |
| JP (1) | JP7445609B2 (https=) |
| KR (1) | KR20210057704A (https=) |
| CN (1) | CN112638382B (https=) |
| WO (1) | WO2019234197A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4072547A1 (en) * | 2019-12-13 | 2022-10-19 | Institut National De La Sante Et De La Recherche Medicale - Inserm | Epac1 inhibitors for the treatment of idiopathic pulmonary fibrosis |
| WO2021250231A1 (en) * | 2020-06-12 | 2021-12-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Thienopyridine derivatives for use in the treatment of coronavirus infection |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60325051D1 (de) * | 2002-06-06 | 2009-01-15 | Boehringer Ingelheim Pharma | SUBSTITUIERTE 3-AMINO-THIENO(2,3-b)PYRIDINE-2-AMIDE UND HERSTELLUNGSVERFAHREN SOWIE DEREN VERWENDUNG |
| AU2007275221A1 (en) * | 2006-07-20 | 2008-01-24 | Allen J. Borchardt | Benzothiophene inhibitors of RHO kinase |
| US20110077250A1 (en) * | 2009-06-26 | 2011-03-31 | Ryder Sean | Compounds for modulating rna binding proteins and uses therefor |
| US9751838B2 (en) | 2012-10-02 | 2017-09-05 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Tetrahydroquinoline derivatives and their use as Epac inhibitors |
| EP2928470A4 (en) * | 2012-12-07 | 2015-12-16 | Siga Technologies Inc | THIENOPYRIDINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF DENGUE VIRUS INFECTIONS |
| AU2014342811B2 (en) | 2013-10-15 | 2019-01-03 | Board Of Regents Of The University Of Texas System | Compositions and methods of modulating short-chain dehydrogenase activity |
-
2019
- 2019-06-06 US US15/734,695 patent/US20210230179A1/en active Pending
- 2019-06-06 EP EP19729737.7A patent/EP3801511A1/en active Pending
- 2019-06-06 CN CN201980037932.4A patent/CN112638382B/zh active Active
- 2019-06-06 JP JP2020568471A patent/JP7445609B2/ja active Active
- 2019-06-06 KR KR1020207035139A patent/KR20210057704A/ko active Pending
- 2019-06-06 WO PCT/EP2019/064886 patent/WO2019234197A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021513534A5 (https=) | ||
| JP4129286B2 (ja) | 新規チアゾリジン−４−オン誘導体 | |
| JP2024514837A5 (https=) | ||
| JP2019517475A5 (https=) | ||
| JP4792025B2 (ja) | ５−ヒドロキシインドール−３−カルボン酸エステル類誘導体およびその用途 | |
| JP2005523922A5 (https=) | ||
| JP2017537940A5 (https=) | ||
| JP2018127459A5 (https=) | ||
| JP2008504265A5 (https=) | ||
| JP2018538304A5 (https=) | ||
| JP2010527983A5 (https=) | ||
| JP2010511721A5 (https=) | ||
| JP2013515037A5 (https=) | ||
| JP2009537469A5 (https=) | ||
| AR063351A1 (es) | DERIVADOS DE PURINA Y DE PIRIMIDINAS CONDENSADAS, COMPOSICION Y SU USO EN LA PREPARACIoN DE UN MEDICAMENTO PARA INHIBIR EL HSP90 EN UNA CELULA. | |
| JP2018135343A5 (https=) | ||
| JP2010527985A5 (https=) | ||
| JP2022525069A5 (https=) | ||
| JPWO2023195529A5 (https=) | ||
| JP2024516033A5 (https=) | ||
| JP2023504542A5 (https=) | ||
| JP2020128426A5 (https=) | ||
| JP2021527071A5 (https=) | ||
| JP2024508526A5 (https=) | ||
| JP2020511450A5 (https=) |